taurine has been researched along with Myocardial Ischemia in 33 studies
Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).
| Excerpt | Relevance | Reference |
|---|---|---|
| "The protective effect of taurine (CAS 107-35-7) against reperfusion-induced arrhythmias has been investigated in isolated perfused rat heart (Langendorff method)." | 7.70 | Protective effects of taurine against reperfusion-induced arrhythmias in isolated ischemic rat heart. ( Chahine, R; Feng, J, 1998) |
| "taurine (200 mg/kg) was intravenously injected 5 min before heart ischemia." | 5.32 | [Effects of taurine on rabbit cardiomyocyte apoptosis during ischemia/reperfusion injury]. ( Ji, ES; Li, AY; Li, Q; Ma, ZH; Zhao, SM, 2004) |
| "The antiarrhythmic effect of taurepar, an N-phenylalkyl derivative of taurine, was examined in experiments on rats subjected to acute myocardial ischemia/reperfusion leading to arrhythmia development." | 3.81 | Antiarrhythmic Activity of Taurepar during Ischemic and Reperfusion Damage to Myocardium. ( Bul'on, VV; Krylova, IB; Sapronov, NS; Selina, EN; Shabanov, PD, 2015) |
| "Experiments on rats with myocardial ischemia modeled by occlusion of the left coronary artery aggravated by alimentary dislipoproteinemia showed that therapy with taurepar (50 mg/kg), a taurine derivative, decreased blood corticosterone concentration and increased the level of endogenous testosterone, which attests to normalization of the compensatory-adaptive and gonadotropic functions of the organism." | 3.76 | Pharmacological correction of testosterone deficiency during experimental myocardial ischemia. ( Fedotova, YO; Khnychenko, LK; Okunevich, IV; Sapronov, NS, 2010) |
| "Taurine (TA) administered exogenously before the induction of myocardial ischemia decreases lactic acid production and increases pyruvic acid production during ischemia." | 3.75 | Taurine-mediated cardioprotection is greater when administered upon reperfusion than prior to ischemia. ( Fukumoto, Y; Iguro, Y; Miyamoto, TA; Nakamura, K; Sakata, R; Ueno, T; Yotsumoto, G, 2009) |
| " Stroke mortality was associated positively with Na and Na/K ratio and phospholipid arachidonic acid (AA), and negatively with TC and K." | 3.73 | Male cardiovascular mortality and dietary markers in 25 population samples of 16 countries. ( Ikeda, K; Liu, L; Mizushima, S; Nara, Y; Yamori, Y, 2006) |
| "The protective effect of taurine (CAS 107-35-7) against reperfusion-induced arrhythmias has been investigated in isolated perfused rat heart (Langendorff method)." | 3.70 | Protective effects of taurine against reperfusion-induced arrhythmias in isolated ischemic rat heart. ( Chahine, R; Feng, J, 1998) |
| "taurine (200 mg/kg) was intravenously injected 5 min before heart ischemia." | 1.32 | [Effects of taurine on rabbit cardiomyocyte apoptosis during ischemia/reperfusion injury]. ( Ji, ES; Li, AY; Li, Q; Ma, ZH; Zhao, SM, 2004) |
| "Taurine (20mM) treatment attenuated simulated ischemia-induced decline in the activity of Akt." | 1.32 | Taurine prevents the ischemia-induced apoptosis in cultured neonatal rat cardiomyocytes through Akt/caspase-9 pathway. ( Azuma, J; Fujio, Y; Ito, T; Matsuda, T; Schaffer, SW; Takahashi, K; Takatani, T; Uozumi, Y, 2004) |
| "Taurine was measured with HPLC." | 1.32 | Augmented taurine release is not the mechanism of ischemic preconditioning's cardioprotection. ( Cohen, MV; Downey, JM; Krieg, T; Schaffer, SW; Yang, XM, 2004) |
| "Taurine was added at a concentration of 0." | 1.32 | Protective effect of taurine against free radicals damage in the rat myocardium. ( Aftimos, G; Chahine, R; Chamat, S; Esseily, F; Hanna, J; Mounayar, A; Nader, M, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (15.15) | 18.2507 |
| 2000's | 20 (60.61) | 29.6817 |
| 2010's | 8 (24.24) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kulthinee, S | 3 |
| Wyss, JM | 3 |
| Roysommuti, S | 3 |
| Krylova, IB | 1 |
| Bul'on, VV | 1 |
| Selina, EN | 1 |
| Sapronov, NS | 3 |
| Shabanov, PD | 1 |
| Yang, YJ | 2 |
| Han, YY | 1 |
| Chen, K | 1 |
| Zhang, Y | 2 |
| Liu, X | 1 |
| Li, S | 1 |
| Wang, KQ | 2 |
| Ge, JB | 2 |
| Liu, W | 1 |
| Zuo, J | 2 |
| Miyamoto, TA | 2 |
| Ueno, T | 1 |
| Iguro, Y | 1 |
| Yotsumoto, G | 1 |
| Fukumoto, Y | 1 |
| Nakamura, K | 1 |
| Sakata, R | 1 |
| Jirakulsomchok, D | 1 |
| Aberg, AM | 1 |
| Ahlström, K | 1 |
| Abrahamsson, P | 1 |
| Waldenström, A | 3 |
| Ronquist, G | 3 |
| Hauck, P | 1 |
| Johansson, G | 1 |
| Biber, B | 1 |
| Haney, M | 1 |
| Khnychenko, LK | 2 |
| Okunevich, IV | 1 |
| Fedotova, YO | 1 |
| Li, AY | 1 |
| Ji, ES | 1 |
| Zhao, SM | 1 |
| Ma, ZH | 1 |
| Li, Q | 1 |
| Yang, L | 1 |
| Liu, XY | 1 |
| Jia, JG | 1 |
| Qian, JY | 1 |
| Bäckström, T | 1 |
| Goiny, M | 1 |
| Lockowandt, U | 1 |
| Liska, J | 1 |
| Franco-Cereceda, A | 1 |
| Schaffer, SW | 7 |
| Pastukh, V | 1 |
| Solodushko, V | 2 |
| Kramer, J | 1 |
| Azuma, J | 5 |
| Zafodskaia, IS | 1 |
| Takahashi, K | 5 |
| Ohyabu, Y | 2 |
| Takatani, T | 3 |
| Itoh, T | 1 |
| Warskulat, U | 1 |
| Flögel, U | 1 |
| Jacoby, C | 1 |
| Hartwig, HG | 1 |
| Thewissen, M | 1 |
| Merx, MW | 1 |
| Molojavyi, A | 1 |
| Heller-Stilb, B | 1 |
| Schrader, J | 1 |
| Häussinger, D | 1 |
| Modi, P | 1 |
| Suleiman, MS | 3 |
| Uozumi, Y | 2 |
| Matsuda, T | 2 |
| Ito, T | 2 |
| Fujio, Y | 2 |
| Melis, GC | 1 |
| ter Wengel, N | 1 |
| Boelens, PG | 1 |
| van Leeuwen, PA | 1 |
| Krieg, T | 1 |
| Yang, XM | 1 |
| Downey, JM | 1 |
| Cohen, MV | 1 |
| Kavianipour, M | 1 |
| Wikström, G | 2 |
| Hanna, J | 1 |
| Chahine, R | 2 |
| Aftimos, G | 1 |
| Nader, M | 1 |
| Mounayar, A | 1 |
| Esseily, F | 1 |
| Chamat, S | 1 |
| Yamori, Y | 2 |
| Liu, L | 2 |
| Mizushima, S | 2 |
| Ikeda, K | 2 |
| Nara, Y | 2 |
| Oriyanhan, W | 1 |
| Yamazaki, K | 1 |
| Miwa, S | 1 |
| Takaba, K | 1 |
| Ikeda, T | 1 |
| Komeda, M | 1 |
| Moffatt, AC | 1 |
| Dihmis, WC | 1 |
| Caputo, M | 1 |
| Hutter, JA | 1 |
| Angelini, GD | 1 |
| Bryan, AJ | 1 |
| Allo, SN | 1 |
| Bagby, L | 1 |
| Feng, J | 1 |
| Liess, C | 1 |
| Radda, GK | 1 |
| Clarke, K | 1 |
| Zemgulis, V | 1 |
| Henze, A | 1 |
| Thelin, S | 1 |
| Miura, A | 1 |
| Miki, T | 1 |
| Lazzarino, G | 1 |
| Corsico, N | 1 |
| Tavazzi, B | 1 |
| di Pierro, D | 1 |
| Arrigoni-Martelli, E | 1 |
| Giardina, B | 1 |
2 reviews available for taurine and Myocardial Ischemia
| Article | Year |
|---|---|
Glutamine: recent developments in research on the clinical significance of glutamine.
Topics: Animals; Clinical Trials as Topic; Dietary Supplements; Glutamine; Glutathione; Humans; Intestinal M | 2004 |
New concepts in the cardioprotective action of magnesium and taurine during the calcium paradox and ischaemia of the heart.
Topics: Animals; Calcium; Calcium Channels; Carrier Proteins; Guinea Pigs; Humans; Intracellular Fluid; Magn | 1994 |
31 other studies available for taurine and Myocardial Ischemia
| Article | Year |
|---|---|
Taurine Supplementation Inhibits Cardiac and Systemic Renin-Angiotensin System Overactivity After Cardiac Ischemia/Reperfusion in Adult Female Rats Perinatally Depleted of Taurine Followed by High Sugar Intake.
Topics: Animals; Dietary Sugars; Dietary Supplements; Female; Myocardial Ischemia; Pregnancy; Rats; Rats, Sp | 2019 |
Taurine supplementation prevents the adverse effect of high sugar intake on arterial pressure control after cardiac ischemia/reperfusion in female rats.
Topics: Animals; Arterial Pressure; Baroreflex; Cardiotonic Agents; Cytoprotection; Dietary Carbohydrates; D | 2015 |
Antiarrhythmic Activity of Taurepar during Ischemic and Reperfusion Damage to Myocardium.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Male; Myocardial Ischemia; Myocardial Reperfu | 2015 |
TonEBP modulates the protective effect of taurine in ischemia-induced cytotoxicity in cardiomyocytes.
Topics: Animals; Male; Myocardial Ischemia; Myocytes, Cardiac; NFATC Transcription Factors; Random Allocatio | 2015 |
Taurine-mediated cardioprotection is greater when administered upon reperfusion than prior to ischemia.
Topics: Animals; Cardiotonic Agents; In Vitro Techniques; Myocardial Ischemia; Rats; Reperfusion; Taurine | 2009 |
High sugar intake exacerbates cardiac reperfusion injury in perinatal taurine depleted adult rats.
Topics: Animals; Baroreflex; Blood Pressure; Body Weight; Dietary Carbohydrates; Female; Heart Rate; Humans; | 2010 |
Ischaemic pre-conditioning means an increased adenosine metabolism with decreased glycolytic flow in ischaemic pig myocardium.
Topics: Adenosine; Animals; Blood Glucose; Body Temperature; Energy Metabolism; Female; Glycerol; Glycogen; | 2010 |
Pharmacological correction of testosterone deficiency during experimental myocardial ischemia.
Topics: Animals; Corticosterone; Dietary Fats; Dyslipidemias; Male; Myocardial Ischemia; Rats; Taurine; Test | 2010 |
[Effects of taurine on rabbit cardiomyocyte apoptosis during ischemia/reperfusion injury].
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Male; Myocardial Ischemia; Myocytes, Cardiac; Rab | 2004 |
Low-dose taurine upregulates taurine transporter expression in acute myocardial ischemia.
Topics: Adult; Aged; Animals; Apoptosis; Carboxy-Lyases; Cell Hypoxia; Cell Line; Female; Histocytochemistry | 2013 |
Cardiac outflow of amino acids and purines during myocardial ischemia and reperfusion.
Topics: Amino Acids; Animals; Aspartic Acid; Female; Guanosine; Hemodynamics; Hypoxanthine; Inosine; Male; M | 2003 |
Effect of ischemia, calcium depletion and repletion, acidosis and hypoxia on cellular taurine content.
Topics: Acidosis; Animals; Calcium; Cells, Cultured; Hypoxia; In Vitro Techniques; Male; Myocardial Ischemia | 2002 |
[Neurogenic heart injuries and their pharmacological correction by a new taurine derivative].
Topics: Animals; Autonomic Nervous System Diseases; Myocardial Ischemia; Myocardium; Rats; Taurine | 2002 |
Taurine renders the cell resistant to ischemia-induced injury in cultured neonatal rat cardiomyocytes.
Topics: Animals; Animals, Newborn; Apoptosis; bcl-2-Associated X Protein; Cells, Cultured; Myocardial Ischem | 2003 |
Taurine transporter knockout depletes muscle taurine levels and results in severe skeletal muscle impairment but leaves cardiac function uncompromised.
Topics: Animals; Carbon Dioxide; Cardiac Pacing, Artificial; Carrier Proteins; Cations; Dobutamine; Echocard | 2004 |
Myocardial taurine, development and vulnerability to ischemia.
Topics: Animals; Biomarkers; Child; Female; Humans; Infant; Male; Myocardial Ischemia; Myocardial Reperfusio | 2004 |
Taurine prevents the ischemia-induced apoptosis in cultured neonatal rat cardiomyocytes through Akt/caspase-9 pathway.
Topics: Animals; Animals, Newborn; Apoptosis; Caspase 9; Caspases; Cells, Cultured; Cytoprotection; Myocardi | 2004 |
Augmented taurine release is not the mechanism of ischemic preconditioning's cardioprotection.
Topics: Animals; Female; Heart; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Male; Myocardial | 2004 |
Validity of elevated interstitial levels of taurine as a predictor of myocardial ischemic injury.
Topics: Animals; Area Under Curve; Ischemia; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfus | 2004 |
Protective effect of taurine against free radicals damage in the rat myocardium.
Topics: Administration, Oral; Animals; Free Radical Scavengers; In Vitro Techniques; Male; Myocardial Ischem | 2004 |
Male cardiovascular mortality and dietary markers in 25 population samples of 16 countries.
Topics: Age Factors; Aged; Americas; Analysis of Variance; Arachidonic Acid; Asia; Australia; Biomarkers; Ch | 2006 |
Molecular mechanisms of cardioprotection by taurine on ischemia-induced apoptosis in cultured cardiomyocytes.
Topics: Animals; Apoptosis; Cardiotonic Agents; Caspases; Cells, Cultured; Enzyme Activation; Mitochondria; | 2006 |
Regionally perfused taurine. Part I. Minimizes lactic acidosis and preserves CKMB and myocardial contractility after ischemia/reperfusion.
Topics: Animals; Cardioplegic Solutions; Cardiotonic Agents; Creatine Kinase, MB Form; DNA; Hypothermia; Lac | 2006 |
Effect of ischaemia and reperfusion on the intracellular concentration of taurine and glutamine in the hearts of patients undergoing coronary artery surgery.
Topics: Adenosine Triphosphate; Aged; Bicarbonates; Biomarkers; Blood; Calcium Chloride; Cardioplegic Soluti | 1997 |
Taurine depletion, a novel mechanism for cardioprotection from regional ischemia.
Topics: Animals; beta-Alanine; In Vitro Techniques; Male; Myocardial Infarction; Myocardial Ischemia; Myocar | 1997 |
Protective effects of taurine against reperfusion-induced arrhythmias in isolated ischemic rat heart.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography; Free Radical Scavengers; | 1998 |
Metabolite and water apparent diffusion coefficients in the isolated rat heart: effects of ischemia.
Topics: Analysis of Variance; Animals; Creatinine; Diffusion; Magnetic Resonance Spectroscopy; Male; Myocard | 2000 |
Nucleoside transport inhibition in ischemic myocardium results in enhanced taurine efflux.
Topics: Adenosine; Animals; Biological Transport; Dipyridamole; Hypoxanthine; Inosine; Lactates; Microdialys | 2001 |
Distribution of twenty-four hour urinary taurine excretion and association with ischemic heart disease mortality in 24 populations of 16 countries: results from the WHO-CARDIAC study.
Topics: Circadian Rhythm; Cross-Sectional Studies; Databases as Topic; Female; Global Health; Humans; Male; | 2001 |
Taurine prevents ischemia damage in cultured neonatal rat cardiomyocytes.
Topics: Animals; Animals, Newborn; Cardiotonic Agents; Cells, Cultured; Heart Injuries; Intracellular Membra | 2000 |
[L-propionylcarnitine taurine amide induces the metabolic recovery of the isolated postischemic rat heart].
Topics: Animals; Carnitine; Drug Evaluation, Preclinical; Energy Metabolism; Heart; In Vitro Techniques; Mal | 1992 |